ELAB
PMGC Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.78
+1.27%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$4.69
From 52W high−99.94%
Volume131906.00
Market cap$3.87M
P/E (TTM)—
P/S (TTM)6.6x
Div yield—
Key dataSep 18, 2026
Open
$4.69
From 52W high
−99.94%
Volume
131906.00
Market cap
$3.87M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.1x
P/E (TTM)
—
RSI (14)
33.0
MomentumView details →
1D Return
+1.27%
YTD Return
−99.66%
SummaryUpdated Jun 1, 2026
PMGC Holdings Inc. (NASDAQ:ELAB) is a biopharmaceutical company founded in 2020 and based in Newport Beach, California. The company was formerly known as Elevai Labs, Inc. before changing its name to PMGC Holdings Inc. in December 2024. PMGC went public in November 2023 and focuses on developing cutting-edge aesthetic medicines and therapeutic products, with particular emphasis on addressing obesity-related challenges through innovative probiotic approaches.
Similar companies
Latest newsMore news →
PMGC Holdings Inc. (Nasdaq: ELAB) secured a five-year royalty stream from the sale of Elevai Skincare under an executed payment agreement with Longevity Health Holdings.2d agoNorthStrive Companies Inc. granted PMGC Holdings Inc. a limited, non-exclusive, non-transferable, revocable, and royalty-free license to use the NorthStrive Marks for a five-year term, with PMGC paying a license fee of $1.00.25d agoPMGC Holdings terminated a previously announced acquisition letter of intent following a due diligence review.25d ago